Hopkinton biopharmaceutical Spring Bank hopes to raise $37.5M Hopkinton-based Spring Bank Pharmaceuticals wants to raise $37.5 million to fund clinical trials, studies and research and other corporate purposes. Biostage to withdraw SEC registration Holliston biotech Biostage is seeking to withdraw a registration statement with the SEC filed nearly one year ago after no securities had been issued or sold under the statement. Boston Scientific eyes reintroducing recalled, remade product Boston Scientific will soon submit the final technical module to the U.S. Food and Drug Administration for a heart valve product. Hologic subsidiary lands laughing gas rights A subsidiary of Marlborough medical device firm Hologic has landed the U.S. and Canadian distribution rights of a Pennsylvania medical equipment manufacturer’s nitrous oxide and oxygen systems. |